Sign in

Private company

G Medical Innovations Holdings Ltd.

G Medical Innovations Holdings Ltd. is a surgical and medical instruments and apparatus company.1

Last updated Oct 21, 2026.

Overview

$4.4MRevenue, fiscal 20222
-$25.1MNet income, fiscal 20222
  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersE91
  • Incorporated inCayman Islands3
  • Business address5 Oppenheimer St., Rehovot, L3 76701053
  • Filer categoryNon-accelerated filer, Emerging growth company3
  • Legal formOther

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

17.7%Gross margin2
-500.3%Operating margin2
-567.1%Net margin2
-10.9%Revenue growth, 20222

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue0¢$113.0K
  • Research and development7¢$2.3M
  • Selling, general and admin64¢$20.6M
  • Interest29¢$9.4M
  • Income tax0¢$16.0K

Out of $4.4M in revenue.2 The company lost money this year.

Financial statements

Revenue42$4.4M in 2022−20% since 2019
0$2.0M$4.0M$6.0M2019: $5.5M$5.5M20192020: $4.9M$4.9M2020−11%2021: $5.0M$5.0M2021+1%2022: $4.4M$4.4M2022−11%
Gross profit42$784.0K in 2022
-$500.0K0$500.0K$1.0M$1.5M$2.0M2019: -$223.0K-$223.0K20192020: $667.0K$667.0K20202021: $1.5M$1.5M2021+126%2022: $784.0K$784.0K2022−48%
Operating income42-$22.1M in 2022+73% since 2019
-$30.0M-$20.0M-$10.0M02019: -$12.8M-$12.8M20192020: -$12.3M-$12.3M2020−4%2021: -$11.0M-$11.0M2021−11%2022: -$22.1M-$22.1M2022+102%
Net income2-$25.1M in 2022+98% since 2020
-$30.0M-$20.0M-$10.0M02020: -$12.7M-$12.7M20202021: -$14.9M-$14.9M2021+17%2022: -$25.1M-$25.1M2022+68%
Fiscal year20182019202020212022
Revenue$5.5M4$4.9M2$5.0M2$4.4M2
Cost of revenue$66.0K2$113.0K2
Gross profit-$223.0K4$667.0K2$1.5M2$784.0K2
Research and development$1.7M2$2.3M2
Selling, general and admin$10.8M2$20.6M2
Operating income-$12.8M4-$12.3M2-$11.0M2-$22.1M2
Interest$4.5M2$9.4M2
Income before tax-$14.6M2-$13.9M2
Income tax-$3.0K2$16.0K2
Net income-$12.7M2-$14.9M2-$25.1M2
Earnings per share-$3.494-$59.672-$45.492-$34.172
Earnings per share (diluted)-$3.494-$59.672-$45.492-$34.172
Shares (weighted, basic)324.5K shares2720.9K shares2
Shares (weighted, diluted)324.5K shares2720.9K shares2

Compare G Medical Innovations Holdings Ltd. with another company

Corporate structure

G Medical Innovations Holdings Ltd. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of G Medical Innovations Holdings Ltd.

  • Jonathan Brian Rubini Filed SC 13D/A on G Medical Innovations Holdings Ltd., latest Apr 12, 2024 (4 filings since Feb 3, 2023)
  • Yacov Geva Filed SC 13D/A on G Medical Innovations Holdings Ltd., latest Aug 25, 2023 (4 filings since Feb 22, 2022)
  • BIGGER CAPITAL FUND L P Filed SC 13G/A on G Medical Innovations Holdings Ltd., latest Aug 18, 2023 (2 filings since Apr 6, 2023)
  • JPMorgan Chase Filed SC 13G/A on G Medical Innovations Holdings Ltd., latest Aug 8, 2023 (2 filings since Jan 31, 2023)
  • AWM Investment Company, Inc. Filed SC 13G/A on G Medical Innovations Holdings Ltd., latest May 10, 2023 (2 filings since Apr 11, 2023)
  • G Medical Innovations Holdings Ltd. E9

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What G Medical Innovations Holdings Ltd. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, net$2.6M2 Dec 31, 2022$1.8M2 Dec 31, 2021+51.0%
Operating-lease assets (leased space)$384.0K2 Dec 31, 2022$380.0K2 Dec 31, 2021+1.1%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$295.0K2 Dec 31, 2022$6.0M2 Dec 31, 2021−95.1%

Inventory

ItemLatestA year beforeChange
Inventory, total$292.0K2 Dec 31, 2022$355.0K2 Dec 31, 2021−17.7%

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerBenny Tal named Feb 24, 2022 to Oct 25, 20235
  • Executive OfficerDavid Seligman named Oct 25, 20235
  • Executive OfficerDror Nuriel-Roth named Feb 24, 2022 to Oct 25, 20235
  • Executive OfficerOded Shahar named Feb 24, 2022 to Oct 25, 20235
  • Executive Officer, DirectorYacov Geva named Feb 24, 2022 to Oct 25, 20235
  • Executive Officer, DirectorKobi Ben-Efraim named Feb 24, 2022 to May 16, 20226
  • DirectorKenneth Melani named Feb 24, 2022 to Oct 25, 20235
  • DirectorUrs Wettstein named Feb 24, 2022 to Oct 25, 20235
  • DirectorYeshoshua Jacob Gleitman named Oct 25, 20235
  • DirectorZeev Rotstein named Feb 24, 2022 to Oct 25, 20235
  • DirectorBrendan de Kauwe named Feb 24, 2022 to May 16, 20226
  • DirectorChanan Epstein named Feb 24, 2022 to May 16, 20226
  • DirectorYehoshua Gleitman named Feb 24, 2022 to May 16, 20226

Filings

122 filings to the SEC since October 2021: 2 annual reports, 2 insider forms, 14 large holders, 3 private raises, 101 other. The latest 20:

  1. Jul 22, 2024RW REGISTRATION WITHDRAWAL EDGAR
  2. Apr 12, 2024SC 13D/A AMENDMENT NO. 3 TO SCHEDULE 13D EDGAR
  3. Feb 7, 2024SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D EDGAR
  4. Dec 18, 20236-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  5. Nov 29, 20236-K CURRENT REPORT EDGAR
  6. Oct 25, 2023D EDGAR
  7. Oct 24, 2023SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D EDGAR
  8. Oct 10, 20236-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  9. Sep 22, 20236-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  10. Sep 13, 20236-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  11. Aug 25, 20236-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  12. Aug 25, 2023SC 13D/A AMENDMENT NO. 2 TO SCHEDULE 13D EDGAR
  13. Aug 25, 20236-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  14. Aug 25, 20236-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  15. Aug 23, 20236-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  16. Aug 18, 2023SC 13G/A EDGAR
  17. Aug 17, 20236-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  18. Aug 8, 2023SC 13G/A FILING G MEDICAL INNOVATIONS HOLDINGS LTD. EDGAR
  19. Aug 7, 20236-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  20. Jul 27, 2023F-1 REGISTRATION STATEMENT EDGAR

The 122 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

2 open-market trades by officers, directors and large owners since October 2021: 0 buys and 2 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Apr 3, 2023AWM Investment Company, Inc.10% ownerSale300,000$0.73$219.0KForm 4
Mar 31, 2023AWM Investment Company, Inc.10% ownerSale437,500$1.02$446.2KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$20.6M 2022–2023
Money received by yearMoney received by year, 2022–2023: $20.6M in all. Private raises (Form D) $20.6M.$0$10M$20M$30M2022 · Private raises (Form D): $20.1M20222023 · Private raises (Form D): $500.0K2023
Figures by year
YearPrivate raises (Form D)Total
2023$500.0K$500.0K
2022$20.1M$20.1M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Sep 29, 2023Raised $500,000 in a private offering of equity5 Form D: 1 investor so far Form D
  2. Apr 18, 2022Raised $8 million in a private offering of equity6 Form D: 2 investors so far Form D
  3. Feb 2, 2022Raised $12.1 million in a private offering of equity12 Form D: 2 investors so far Form D

SEC filer profile

How G Medical Innovations Holdings Ltd. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARG Medical Innovations Holdings Ltd.1
  • CIK0001760764
  • Filer statusNon-accelerated filer<br>emerging growth company1
  • Incorporated inCayman Islands1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address5 Oppenheimer St., Rehovot, L3 76701051
  • Phone972-895847771
  • Shares outstanding1,532,794 as of Dec 31, 20222
  • On EDGAR sinceDec 28, 20181
  • Filings177 in all: 6-K (64), CORRESP (16), F-1/A (12), UPLOAD (12), EFFECT (9), F-1 (8), FWP (6), SC 13D/A (5)1
    All 30 form types

    DRS/A (4), SC 13G (4), D (3), DRS (3), RW (3), SC 13G/A (3), 20-F (2), 424B4 (2), 8-A12B (2), CERT (2), DRSLTR (2), POS AM (2), S-8 (2), SC 13D (2), SEC STAFF LETTER (2), 25-NSE (1), 3 (1), 4 (1), 424B5 (1), 6-K/A (1), F-3 (1), NT 20-F (1)

  • Latest filingsAnnual report (20-F) May 16, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12